1760.TW · PBF
Taiwan · RS rating 17 · As of 2026-10-08
| Price | 55.70 TWD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 38 / 28 / 24 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 21 / 23 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | -23.3% |
| Sales growth Q/Q | -1.4% |
| Distance from 52-week high | +21.8% |
| Market cap (USD) | $146.6M |